The Vasomotor Symptoms of Menopause (Hot Flashes) drugs in development market research report provides comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Vasomotor Symptoms of Menopause (Hot Flashes). Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes) and features dormant and discontinued products.
GlobalData tracks 16 drugs in development for Vasomotor Symptoms of Menopause (Hot Flashes) by 16 companies/universities/institutes. The top development phase for Vasomotor Symptoms of Menopause (Hot Flashes) is phase ii with seven drugs in that stage. The Vasomotor Symptoms of Menopause (Hot Flashes) pipeline has 16 drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline products market are: Jiangsu Hansoh Pharmaceutical Group, Dare Bioscience and Acrux.
The key targets in the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline products market include Estrogen Receptor (ESR), Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2), and Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3 or PGR).
The key mechanisms of action in the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline product include Estrogen Receptor (ESR) Agonist with four drugs in Phase III. The Vasomotor Symptoms of Menopause (Hot Flashes) pipeline products include six routes of administration with the top ROA being Oral and two key molecule types in the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline products market including Small Molecule, and Recombinant Protein.
Vasomotor Symptoms of Menopause (Hot Flashes) overview
Vasomotor symptoms of menopause include hot flashes or night sweats that result from the sudden opening of blood vessels close to the skin, usually due to hormonal fluctuations in menopause and perimenopause. These symptoms can also be caused by some medications, estrogen withdrawal, thyroid disease, diabetes, hyperhidrosis, anxiety and panic disorders, obesity, hormonally active tumors, chronic infections, and neurological disorders.
For a complete picture of Vasomotor Symptoms of Menopause (Hot Flashes)’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
